We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Simmons First National
SFNC
$3.35B
| $362K | ﹤0.01% |
12,702
+256
| +2% | +$7.35K |
|
1627
Commerce Bancshares
CBSH
$8.5B
| $361K | ﹤0.01% |
9,556
+499
| +6% | +$18.6K |
|
1628
Comtech Telecommunications
CMTL
$51.8M
| $361K | ﹤0.01% |
16,318
-2,290
| -12% | -$48.8K |
|
|
NXGN
1629
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $361K | ﹤0.01% |
26,626
+3,721
| +16% | +$53.4K |
|
|
AZPN
1630
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $361K | ﹤0.01% |
+5,444
| New | +$361K |
|
1631
Waters Corp
WAT
$36.8B
| $359K | ﹤0.01% |
1,860
+259
| +16% | +$50K |
|
1632
Banc of California
BANC
$3.28B
| $358K | ﹤0.01% |
17,301
-3,958
| -19% | -$82.7K |
|
1633
Strategy Inc
MSTR
$33.5B
| $358K | ﹤0.01% |
27,250
-1,650
| -6% | -$22.2K |
|
1634
Associated Banc-Corp
ASB
$5.81B
| $357K | ﹤0.01% |
14,041
+420
| +3% | +$10.5K |
|
|
CBM
1635
DELISTED
Cambrex Corporation
CBM
| $357K | ﹤0.01% |
7,444
-36
| -0.5% | -$1.78K |
|
|
ALOG
1636
DELISTED
Analogic Corp
ALOG
| $356K | ﹤0.01% |
4,254
-489
| -10% | -$40.4K |
|
1637
Marcus & Millichap
MMI
$1.15B
| $355K | ﹤0.01% |
+10,869
| New | +$324K |
|
1638
Verisk Analytics
VRSK
$26.4B
| $355K | ﹤0.01% |
3,702
+288
| +8% | +$26.1K |
|
1639
Cullen/Frost Bankers
CFR
$10.3B
| $354K | ﹤0.01% |
3,744
+275
| +8% | +$26.5K |
|
1640
Fair Isaac
FICO
$28.7B
| $354K | ﹤0.01% |
2,310
-164
| -7% | -$24.8K |
|
|
TPC
1641
Tutor Perini Cor
TPC
$4.57B
| $352K | ﹤0.01% |
13,904
-1,558
| -10% | -$41.5K |
|
|
PGTI
1642
DELISTED
PGT, Inc.
PGTI
| $352K | ﹤0.01% |
20,873
-3,829
| -16% | -$58.8K |
|
1643
Lindsay Corp
LNN
$1.16B
| $351K | ﹤0.01% |
3,977
-209
| -5% | -$19K |
|
|
WAGE
1644
DELISTED
WageWorks, Inc.
WAGE
| $350K | ﹤0.01% |
5,643
-168
| -3% | -$10.5K |
|
1645
ResMed
RMD
$28.3B
| $349K | ﹤0.01% |
+4,124
| New | +$341K |
|
1646
Revvity
RVTY
$12.3B
| $349K | ﹤0.01% |
4,771
+419
| +10% | +$30.1K |
|
1647
Texas Capital Bancshares
TCBI
$4.31B
| $349K | ﹤0.01% |
3,930
+178
| +5% | +$15.4K |
|
|
VSM
1648
DELISTED
Versum Materials, Inc.
VSM
| $349K | ﹤0.01% |
9,227
+1,463
| +19% | +$57.1K |
|
1649
Boston Beer
SAM
$1.88B
| $347K | ﹤0.01% |
1,816
-26,580
| -94% | -$4.75M |
|
|
QTS
1650
DELISTED
QTS REALTY TRUST, INC.
QTS
| $345K | ﹤0.01% |
6,368
-1,535
| -19% | -$85.5K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.